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Abstract: Glucose-insulin system models are commonly used for identifying insulin sensitivity, either 
for glycaemic control or diagnostic purposes. With physiological, 2-compartment insulin kinetics models, 
accurate kinetic parameter values are necessary to obtain reliable estimates of insulin sensitivity. This 
study combined data from 6 separate, published microdialysis studies to determine the best parameter 
values for the transcapillary diffusion rate (nI) and cellular insulin clearance rate (nC). 
The 6 studies (12 data sets) used microdialysis techniques to assay interstitial insulin concentrations 
simultaneously with plasma insulin concentration samples. The reported arterial insulin concentrations 
were used as input and interstitial insulin concentrations were simulated with the interstitial insulin 
kinetics sub-model. These simulated results were then compared to the reported interstitial measurements 
and an error value calculated as the absolute difference at the original measurement time points, 
normalised by the mean interstitial insulin concentration. The most appropriate set of parameter values 
was determined across the 12 data sets by combining the results. 
The results of this investigation suggest that the most appropriate values for the interstitial insulin kinetic 
parameters are nI = nC = 0.0060 min-1. These parameter values are associated with an effective, 
interstitial insulin half-life t½ = 58 mins, within the range of 25-130 mins reported by others. 
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1. INTRODUCTION 
Glucose-insulin system models are commonly used for 
identifying insulin sensitivity, either for glycaemic control or 
diagnostic purposes. Insulin-mediated glucose uptake 
primarily occurs from the interstitial fluid. Insulin from 
plasma diffuses to the interstitial fluid surrounding tissue 
cells where it binds to cell-wall receptors, activating glucose 
uptake (Jefferson and Cherrington, 2001). Modelling this 
behaviour with two insulin compartments is relatively 
common (Hovorka et al., 2008, Lin et al., 2011, Pielmeier et 
al., 2010, Van Herpe et al., 2006). However, directly 
measuring the kinetic parameter values is difficult, if not 
impossible, especially as many of these models treat the 
remote compartment as an effect compartment with no back-
diffusion, rather than a physiological representation of a fluid 
space. 
This study determines the kinetic parameter values for a two-
compartment physiological model with saturable clearance, 
using data from a number of published microdialysis studies. 
The specific model used is that described by Lin et al. (2011). 
Although this model is very similar to those described by 
Lotz et al. (2008) and Pielmeier et al. (2010), the published 
insulin kinetic parameter values are quite different. Hence 
there is a need for clarification based physiological 
measurements. 
2. SUBJECTS AND METHODS 
This study used data from 6 published studies (see Table 1) 
that used microdialysis to assay interstitial insulin levels 
simultaneously with plasma insulin levels. These 
measurements enabled direct determination of the kinetic 
parameter values.  
 
2.1 Interstitial insulin kinetics model 
The interstitial insulin kinetics model used in this study was 
described by Lin et al. (2011) and is shown in (1). Plasma 
and interstitial insulin concentrations are denoted I and Q, 
respectively. Receptor-bound insulin saturation dynamics are 
characterised by αG. 
There are only two parameters that affect interstitial insulin 
kinetics at physiological concentrations. The parameter nI 
represents the transcapillary diffusion rate between the I and 
Q compartments. The parameter nC represents the 
irreversible cellular insulin clearance rate. Thus, only one 
equation is required, and the desired variables are separated 
from any other equations, data, or parameter values, 
eliminating any other potential biases 
  
     
?̇? = 𝑛𝐼(𝐼 − 𝑄) − 𝑛𝐶𝑄1 + 𝛼𝐺𝑄 1 
The transformation shown in (2) defines γ, the steady state 
ratio of interstitial insulin (Q) to plasma insulin (I) 
concentrations, at physiological levels. In this study, the 
parameters nI and γ are identified, from which nC can be 
calculated. The parameter γ provides a more intuitive insight 
to the relative interstitial insulin concentration than nC. 
𝛾 = 𝑛𝐼
𝑛𝐼 + 𝑛𝐶 2 
 
2.2 Microdialysis analysis 
To identify nI and γ in a direct, physiological manner, data 
was used from 6 published studies (12 data sets). These 
studies used microdialysis to determine interstitial insulin 
concentrations. Plasma insulin concentrations were taken 
simultaneously. The 6 independent studies were conducted 
using infused and endogenous insulin at varying 
physiological and supra-physiological levels. Data used in 
this analysis was taken from the studies listed in Table 1. 
Using reported arterial insulin concentrations (I) as input, 
interstitial concentrations (Q) were simulated with the 
interstitial insulin kinetics sub-model described in (1). These 
simulated results were then compared to the reported 
interstitial measurements.  
A grid-search was performed over a range of nI and γ values 
to find the region of minimum error between simulated and 
measured interstitial insulin concentrations. For any given 
parameter pair, the error value was defined as the sum of 
absolute differences between the simulated and measured 
concentrations at the experimental sampling points, divided 
by the average interstitial insulin level during the experiment. 
Errors across all data sets were evaluated by two methods to 
ensure robust parameter values that were not skewed by data 
from a single study. Specifically:  
I. Each error value was weighted equally, by summing 
absolute error values at each (nI, γ) pair across all 12 
data sets. 
II. Each study was weighted equally by scaling the 
calculated errors into the range 0-1 prior to summing 
across all data sets. 
 
 
Table 1. Published microdialysis studies used to investigate interstitial insulin kinetic parameters. 
Study Study Method Study Population N Interstitial sampling 
location 
Jansson et al. (1993) Euglycaemic-hyperinsulinaemic clamp Healthy non-obese 5 
Abdominal 
subcutaneous fat 




Body fat <=12% 3 
Subcutaneous lymph 




Body fat 13-21% 5 
Subcutaneous lymph 




Body fat 22-35% 3 
Subcutaneous lymph 




Body fat >=36% 2 
Subcutaneous lymph 
vessel; lower leg 
Sjostrand et al. 
(2002) 
Euglycaemic-
hyperinsulinaemic clamp Healthy lean 10 Forearm muscle 
Euglycaemic-
hyperinsulinaemic clamp Healthy obese 10 Forearm muscle 
Gudbjornsdottir et al. 
(2003) 
Euglycaemic-
hyperinsulinaemic clamp Healthy lean 10 Forearm muscle 
Herkner et al. (2003) 
Oral glucose tolerance test Healthy lean 8 Mid thigh muscle 
Euglycaemic-
hyperinsulinaemic clamp Healthy lean 8 Mid thigh muscle 
Sjostrand et al. 
(2005a) 
Oral glucose tolerance test Healthy lean 10 Forearm muscle 
Oral glucose tolerance test Healthy obese 10 Forearm muscle 
 
  
     
3. RESULTS & DISCUSSION 
Grid-search results for the parameter optimisation using 
published microdialysis data are shown in Figure 1. The left 
panel shows the results from method I where each error value 
was weighted equally. The right panel shows the results from 
method II where each study was weighted equally. Data from 
the Herkner et al. (2003) clamp study have been omitted as 
the minimum error was located at nI = 0, which was not 
physiologically reasonable. 
Figure 1 shows the regions around the minimum error points, 
where the contours indicate errors 1% and 5% greater than 
the minimum values. The parameter set, nI =0.0060 min-1, γ 
= 0.5 (nI = nC) is enclosed within the 5% region and thus 
provides a good compromise between the two identified 
minima and previous results. The choice of γ = 0.5 is 
consistent with that used by Lin et al. {, 2011 #2257} and 
similar to the value of 0.6 used by Lotz et al. {, 2008 #1707} 
and Pielmeier  et al. {, 2010 #3278}.  
Table 2 shows the individual optimal parameter values for 
each dataset. The associated errors are shown along with the 
error obtained using the selected parameter set, nI 
=0.0060 min-1, γ = 0.5. The errors presented are unitless and 
represent the mean absolute error across the experimental 
sampling points for that study, normalised by the average 
interstitial insulin concentration during the experiment. 
The optimal parameter values vary widely across the 12 data 
sets, particularly for nI. This variability could reflect the 
inter-patient differences, poor mixing of interstitial fluid, the 
difficulty of microdialysis techniques or lack of sensitivity to 
these parameter values. 
Figure 2 shows two contrasting examples of the simulated 
and measured interstitial insulin concentrations using the 
selected parameter values. Panels A and B show data from 
the Castillo study (1994) for subjects with body fat in the 
range of 13-21%. Panels C and D show data from the oral 
glucose tolerance test (OGTT) study by Herkner et al. (2003). 
Measured arterial insulin is presented in the top panels (A 
and C), with measured and modelled interstitial insulin in the 
bottom (B and D) along with the absolute error between 
them. These two studies had similar insulin concentrations 
and thus make a good comparison. 
The model fit to data is very good for the Castillo study 
(1994) in the left panel, but less so for the Herkner study 
(2003) in the right panel. The interstitial insulin peak at 15 
mins in the Herkner study does not correspond to any feature 
in the plasma insulin profile. The plasma insulin-sampling 
scheme may have missed a peak, the interstitial insulin peak 
may be spurious, or insulin may have been transported to the 
interstitium independent of plasma as the authors’ propose.  
The Herkner study was conducted using oral glucose (75 
grams) to stimulate insulin secretion. Therefore, a sharp 
plasma insulin peak would not be expected (Caumo and Luzi, 
2004), particularly within 15 minutes of glucose ingestion. 
The insulin kinetics model used for this analysis relies on 
passive diffusion of insulin across the endothelium. Hence, 
with no plasma insulin peak to create a sharp concentration 
gradient, the model could not reproduce the reported peak in 
interstitial insulin, resulting in the poor fit. 
 
 
Figure 1. Grid-search error results from microdialysis analysis showing optimal parameter values. The left panel shows the 
results where each error value was weighted equally (method I), and the right panel shows the results where each study was 
weighted equally (method II). Contours are at error 1% and 5% greater than the minimum. Lighter areas represent lower error 





















0 0.005 0.01 0.015 0.02
Minimum: (nI, γ) = (0.0066, 0.45)
  
     
Table 2. Individual results from published microdialysis studies. Study minimum error is associated with the study optimal nI 
and γ. The error at the selected parameter set, nI =0.0060 min-1, γ = 0.5 is also shown. The errors are unitless and represent 
mean absolute error across the measurement points, normalised by the average interstitial insulin concentration. Abbreviations; 
Clamp: Euglycaemic-hyperinsulinaemic clamp; OGTT: Oral glucose tolerance test. 
Study Study 
Method 
Study Population Study 
optimal nI 






selected (nI, γ) 
Jansson et al. 
(1993) Clamp Healthy non-obese 0.0054 0.30 0.142 0.233 
Castillo et al. 
(1994) 
Clamp Healthy:  Body fat <=12% 0.0031 0.53 0.103 0.305 
Clamp Healthy:  Body fat 13-21% 0.0048 0.62 0.038 0.090 
Clamp Healthy:  Body fat 22-35% 0.0041 0.61 0.029 0.101 
Clamp Healthy:  Body fat >=36% 0.0040 0.44 0.044 0.204 
Sjostrand et al. 
(2002) 
Clamp Healthy lean 0.0128 0.48 0.060 0.191 
Clamp Healthy obese 0.0054 0.70 0.057 0.072 
Gudbjornsdottir et 
al. (2003) Clamp Healthy lean 0.0061 0.67 0.143 0.180 
Herkner et al. 
(2003) 
OGTT Healthy lean 0.0116 0.31 0.300 0.458 
Clamp Healthy lean 0 0 0.137 1.546 
Sjostrand et al. 
(2005a) 
OGTT Healthy lean 0.0600 0.57 0.101 0.610 




Figure 2. Two contrasting examples from the simulation of microdialysis data using selected parameter set, nI =0.0060 min-1, 
γ = 0.5. The panels on the left show a good model fit to measured data from Castillo et al. (1994) (body fat 13-21%). The 
panels on the right show a poor fit from Herkner et al. (2003) (OGTT). The upper panels present plasma insulin concentrations 






























































     
Modelled interstitial insulin profiles did not fit either data set 
from the Herkner et al. (2003) study very well. The OGTT 
example from this study is shown in the right panel of Figure 
2. The other data set from Herkner involved a euglycaemic-
hyperinsulinaemic clamp procedure, in which the interstitial 
insulin levels were lower than during the OGTT study (<10 
mU/l), despite sustained higher plasma levels (>65 mU/l for 
60 mins). 
There were no obvious reasons for these poor fits and they 
may be due to the complicated and difficult nature of 
microdialysis sampling of interstitial fluid. As noted 
previously, data from the Herkner et al. (2003) clamp study 
were omitted. 
The remaining studies had mean absolute error values at their 
individual optimal parameter values of less than 15% of their 
average interstitial insulin concentration. At the selected 
parameter set, the errors were less than 30%, except for the 
OGTT study by Sjostrand et al. (2005a). The optimal nI 
values for these two datasets were very high (nI = 0.060 and 
0.040 min-1, respectively), though similar to those used by 
Lotz et al. (2008). Hence, the errors for this study were large 
with the much smaller value of nI = 0.0060 min-1 selected.  
It should be noted that the data from the Sjostrand et al. study 
(2005a) was corrected prior to use in this analysis for the 
error present in the original article, as per their retraction 
(Sjostrand et al., 2005b) 
 
3.1 Comparison of results  
Using direct physiological measurements from 6 published 
microdialysis studies, the most appropriate parameter values 
nI = 0.0060 min-1, γ = 0.5 were identified. γ = 0.5 (nI = nC) is 
unchanged from the values reported by Lin et al. (2011) and 
Lotz et al. (2008). However, nI = 0.0060 min-1 is between the 
values reported in those two studies; nI = 0.003 min-1 and nI 
= 0.0486 min-1. 
The value of nI identified for the ICING model by Lin et al. 
(2011) was approximately 16-times smaller than that used by 
Lotz et al. (2008) for healthy and diabetic subjects. The result 
of this reduction in transcapillary diffusion (nI) and cellular 
insulin clearance rates, was that insulin persisted much longer 
in the interstitial compartment, reflecting the insulin pooling 
and delayed utilization effects observed in critically ill 
patients by Doran et al. (2005) 
The parameter value for nI used by Lotz et al. (2008) was the 
transcapilliary diffusion rate for C-peptide identified by Van 
Cauter et al. (1992). This choice was justified on the grounds 
that insulin and C-peptide have similar molecular weights 
(5800 Da and 3600 Da respectively) and passive properties. 
Parameter values were identified for each individual based on 
age, gender, body surface area and diabetic or obese status, as 
proposed by Van Cauter et al. The mean value identified 
across the study cohort was nI = 0.0486 min-1 (Lotz et al., 
2008).  
A possible reason for the discrepancy between the values 
identified in this study and those of Lotz et al. (2008) is that 
trans-endothelial insulin diffusion is a saturable process (Lin 
et al., 2011). The experimental diffusion rates adopted from 
Van Cauter et al. (1992) are determined by using C-peptide 
measurements. Although C-peptide has very similar 
molecular properties to insulin, it does not go through a high 
and variable degree of first pass extraction in the portal vein 
(Van Cauter et al., 1992). Therefore, its concentration is 
several folds higher than insulin in plasma. If the diffusion 
process is to any level saturable (Thorsteinsson, 1990), the 
rates determined using C-peptide measurements would not be 
reflective of insulin. 
The ‘effective’ or interstitial half-life of insulin is defined by 
the interstitial kinetic parameters in (3) (Lin et al., 2011). 
This half-life characterizes the clearance rate of insulin from 
the interstitium where it effects the uptake of glucose into 
tissue cells. Previously published reports suggest values in 
the range 25-130 mins (Mari and Valerio, 1997, Natali et al., 
2000, Turnheim and Waldhausl, 1988). 
𝑡½ = 𝑙𝑜𝑔𝑒(2)𝑛𝐼 + 𝑛𝐶  3 
The effective half-life associated with the kinetic parameters 
identified by Lin et al. (2011) was t½ = 116 mins. This value 
better matched data from previous studies than the short t½ = 
7 mins used by Lotz et al. (2008). The effective half-life 
insulin determined from the values of nI and nC identified in 
this study is t½ = 58 mins, is also within the range reported 
by previous studies.  
 
4. CONCLUSION 
This study used data from six published microdialysis studies 
to determine the most appropriate parameter values. Using 
direct physiological measurement data from the microdialysis 
studies provided a sound physiological foundation for the 
kinetic parameter values. 
The results of this investigation suggest that the best values 
for the interstitial insulin kinetic parameters are nI = nC = 
0.0060 min-1. These parameter values are associated with an 
effective, interstitial insulin half-life t½ = 58 mins, within the 
range of 25-130 mins reported by others.  
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